BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19584673)

  • 1. Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials.
    Cross NB; Webster AC; Masson P; O'connell PJ; Craig JC
    Transplantation; 2009 Jul; 88(1):7-18. PubMed ID: 19584673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive treatment for kidney transplant recipients.
    Cross NB; Webster AC; Masson P; O'Connell PJ; Craig JC
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD003598. PubMed ID: 19588343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis.
    Pisano A; Bolignano D; Mallamaci F; D'Arrigo G; Halimi JM; Persu A; Wuerzner G; Sarafidis P; Watschinger B; Burnier M; Zoccali C
    Nephrol Dial Transplant; 2020 May; 35(5):878-887. PubMed ID: 31143926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive agents for preventing diabetic kidney disease.
    Lv J; Perkovic V; Foote CV; Craig ME; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2012 Dec; 12():CD004136. PubMed ID: 23235603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
    Huang RS; Cheng YM; Zeng XX; Kim S; Fu P
    Chin Med J (Engl); 2016 Mar; 129(5):562-9. PubMed ID: 26904991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of renin-angiotensin system inhibitors on survival in kidney transplant recipients: A systematic review and meta-analysis.
    Jiang YM; Song TR; Qiu Y; Liu JP; Wang XD; Huang ZL; Lin T
    Kaohsiung J Med Sci; 2018 Jan; 34(1):1-13. PubMed ID: 29310811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN).
    Ruggenenti P; Perna A; Benini R; Remuzzi G
    J Am Soc Nephrol; 1998 Nov; 9(11):2096-101. PubMed ID: 9808096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term outcomes with renin-angiotensin-aldosterone inhibitors in renal transplant recipients: A meta-analysis of randomized controlled trials.
    Liao RX; Lyu XF; Tang WJ; Gao K
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28186357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive agents for preventing diabetic kidney disease.
    Strippoli GF; Craig M; Craig JC
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004136. PubMed ID: 16235351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should ACE inhibitors or calcium channel blockers be used for post-transplant hypertension?
    Seeman T; Feber J
    Pediatr Nephrol; 2021 Mar; 36(3):539-549. PubMed ID: 32060819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
    Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
    Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
    Bangalore S; Kumar S; Kjeldsen SE; Makani H; Grossman E; Wetterslev J; Gupta AK; Sever PS; Gluud C; Messerli FH
    Lancet Oncol; 2011 Jan; 12(1):65-82. PubMed ID: 21123111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from the African-American Study of Kidney Disease and Hypertension: an update.
    Toto RD
    Curr Hypertens Rep; 2006 Oct; 8(5):409-12. PubMed ID: 16965728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: A systematic review, and network meta-analysis.
    Hu Y; Liang L; Liu S; Kung JY; Banh HL
    J Clin Hypertens (Greenwich); 2023 Aug; 25(8):661-688. PubMed ID: 37417783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive treatments in adult autosomal dominant polycystic kidney disease: network meta-analysis of the randomized controlled trials.
    Xue C; Zhou C; Dai B; Yu S; Xu C; Mao Z; Ye C; Chen D; Zhao X; Wu J; Chen W; Mei C
    Oncotarget; 2015 Dec; 6(40):42515-29. PubMed ID: 26636542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin System Blockade Combined With Calcium Channel Blockers Is Superior to Other Combinations in Cardiovascular Protection With Similar Blood Pressure Reduction: A Meta-Analysis in 20,451 Hypertensive Patients.
    Chi C; Tai C; Bai B; Yu S; Karamanou M; Wang J; Protogerou A; Blacher J; Safar ME; Zhang Y; Xu Y
    J Clin Hypertens (Greenwich); 2016 Aug; 18(8):801-8. PubMed ID: 26778747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.
    Psaty BM; Smith NL; Siscovick DS; Koepsell TD; Weiss NS; Heckbert SR; Lemaitre RN; Wagner EH; Furberg CD
    JAMA; 1997 Mar; 277(9):739-45. PubMed ID: 9042847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.